Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 12/2012

01-12-2012 | Case Report

Aseptic meningitis in adult onset Still’s disease

Authors: Bharath Manu Akkara Veetil, Alan H. Yee, Kenneth J. Warrington, Allen J. Aksamit Jr, Thomas G. Mason

Published in: Rheumatology International | Issue 12/2012

Login to get access

Abstract

Adult onset Still’s disease (AOSD) is a systemic inflammatory disease characterized by high-fevers, articular involvement, maculopapular rash, hepatosplenomegaly, lymphadenopathy, and a neutrophilic leukocytosis. Though systemic complications of AOSD or its treatment are well described in the literature, CNS involvement in AOSD is exceedingly rare and can have protean manifestations. We present a patient with AOSD who developed chronic meningitis and sensorineural hearing loss on treatment, with a review of prior reported cases of aseptic meningitis, to highlight this rare complication of this uncommon illness.
Literature
1.
2.
Yamaguchi M et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19(3):424–430PubMed
3.
Magadur-Joly G et al (1995) Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France. Ann Rheum Dis 54(7):587–590PubMedCrossRef
4.
Kontzias A, Efthimiou P (2008) Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances. Drugs 68(3):319–337PubMedCrossRef
5.
Chen DY et al (2004) Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still’s disease. Ann Rheum Dis 63(10):1300–1306PubMedCrossRef
6.
Reginato AJ et al (1987) Adult onset Still’s disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum 17(1):39–57PubMedCrossRef
7.
Hong YH, Lee CK (2008) A case of adult onset Still’s disease with systemic inflammatory response syndrome complicated by fatal status epilepticus. Rheumatol Int 28(9):931–933PubMedCrossRef
8.
Ohta A et al (1990) Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol 17(8):1058–1063PubMed
9.
Tabak F et al (2003) Neutrophilic pleocytosis in cerebrospinal fluid: adult-onset Still’s disease. Intern Med 42(10):1039–1041PubMedCrossRef
10.
Gonday G et al (1981) Still’s disease in the adult (author’s transl). Sem Hop 57(45–46):1885–1889PubMed
11.
Lammle B, Schroder E, Steiger U (1983) Systemic chronic juvenile arthritis (Still’s disease) in adults. Review of the literature. Schweiz Med Wochenschr 113(4):126–137PubMed
12.
Garrote FJ et al (1993) Aseptic meningitis and focal central nervous system involvement in a case of adult onset Still’s disease. J Rheumatol 20(4):765–767PubMed
13.
Marie I et al (1999) Aseptic meningitis and cranial nerve palsy revealing adult-onset Still’s disease. Clin Infect Dis 29(1):220–221PubMedCrossRef
14.
Desai SS, Allen E, Deodhar A (2002) Miller Fisher syndrome in adult onset Still’s disease: case report and review of the literature of other neurological manifestations. Rheumatology (Oxford) 41(2):216–222CrossRef
15.
Kanyerezi BR (1980) Still’s disease in the adults in Uganda. East Afr Med J 57(12):843–846PubMed
16.
Blockmans DE, Knockaert DC, Bobbaers HJ (2000) Still’s disease can cause neutrophilic meningitis. Neurology 54(5):1203–1205PubMedCrossRef
17.
Moris G, Garcia-Monco JC (1999) The challenge of drug-induced aseptic meningitis. Arch Intern Med 159(11):1185–1194PubMedCrossRef
18.
Markusse HM et al (1988) Sensorineural hearing loss in adult onset Still’s disease. Ann Rheum Dis 47(7):600–602PubMedCrossRef
19.
Denault A, Dimopoulos MA, Fitzcharles MA (1990) Meningoencephalitis and peripheral neuropathy complicating adult Still’s disease. J Rheumatol 17(5):698–700PubMed
20.
Sisselman SG (1999) Adult onset Still’s disease presenting as aseptic meningitis in a young healthy female. Del Med J 71(4):181–184PubMed
21.
Nishida T et al (2001) Hemophagocytic syndrome and adult Still’s disease associated with meningoencephalitis and unconsciousness. Intern Med 40(10):1037–1040PubMedCrossRef
Metadata
Title
Aseptic meningitis in adult onset Still’s disease
Authors
Bharath Manu Akkara Veetil
Alan H. Yee
Kenneth J. Warrington
Allen J. Aksamit Jr
Thomas G. Mason
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 12/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1529-8

Other articles of this Issue 12/2012

Rheumatology International 12/2012 Go to the issue

Short Communication

Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab

Original Article

Investigation of the change in CD4+ T cell subset in children with Henoch–Schonlein purpura

Original Article

Low plasma vitamin D levels in patients with familial Mediterranean fever

Original Article

The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome

Original Article

Reevaluation of predictive value of ACL and anti-β2GP1 antibody for thrombosis in patients with systemic lupus erythematosus: from a perspective of a practical world

Original Article

Predictors of early mortality in systemic sclerosis: a case–control study comparing early versus late mortality in systemic sclerosis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits